Suppr超能文献

对影响改良的体内99m锝红细胞标记技术临床应用效果的因素进行评估。

An assessment of factors which influence the effectiveness of the modified in vivo technetium-99m-erythrocyte labeling technique in clinical use.

作者信息

Kelly M J, Cowie A R, Antonino A, Barton H, Kalff V

机构信息

Department of Nuclear Medicine, Alfred Hospital, Melbourne, Victoria, Australia.

出版信息

J Nucl Med. 1992 Dec;33(12):2222-5.

PMID:1460520
Abstract

This study assessed factors which may contribute to suboptimal image quality when the modified in vivo erythrocyte labeling technique is used with standard clinical 99mTc activities. For each assessment duplicate or triplicate blood specimens were withdrawn from > or = 10 patients, into syringes containing 700-900 MBq 99mTc as pertechnetate. After incubation the percent of 99mTc which was not bound to erythrocytes at blood re-injection time (%Unbound 99mTc), was measured and compared when one of four factors was varied. The most significant results, in descending order of measured effect were: [table: see text] Our data suggest that the requirements for optimal erythrocyte labeling with standard clinical 99mTc activities are: (A) Erythrocyte tinning time between 10 and 30 min; (B) blood volume > or = 3 ml; (C) blood incubation time > or = 20 min; and (D) Generator ingrowth time < or = 24 hr.

摘要

本研究评估了在使用标准临床99mTc活度的改良体内红细胞标记技术时,可能导致图像质量欠佳的因素。对于每次评估,从≥10名患者身上采集两份或三份血样,注入含有700 - 900 MBq高锝酸盐形式的99mTc的注射器中。孵育后,在重新注入血液时测量未与红细胞结合的99mTc的百分比(未结合99mTc百分比),并在改变四个因素之一时进行比较。按测量效应从大到小排序,最显著的结果如下:[表格:见原文]我们的数据表明,使用标准临床99mTc活度进行最佳红细胞标记的要求为:(A)红细胞锡化时间在10至30分钟之间;(B)血容量≥3 ml;(C)血液孵育时间≥20分钟;以及(D)发生器生长时间≤24小时。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验